Your browser doesn't support javascript.
loading
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade.
Stein, Julie E; Lipson, Evan J; Cottrell, Tricia R; Forde, Patrick M; Anders, Robert A; Cimino-Mathews, Ashley; Thompson, Elizabeth D; Allaf, Mohamad E; Yarchoan, Mark; Feliciano, Josephine; Wang, Hao; Jaffee, Elizabeth M; Pardoll, Drew M; Topalian, Suzanne L; Taube, Janis M.
Affiliation
  • Stein JE; Department of Dermatology at Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Lipson EJ; Department of Oncology at Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland.
  • Cottrell TR; Department of Pathology at Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Forde PM; Department of Oncology at Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland.
  • Anders RA; Department of Pathology at Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Cimino-Mathews A; Department of Oncology at Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland.
  • Thompson ED; Department of Pathology at Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Allaf ME; Department of Pathology at Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Yarchoan M; Department of Urology at Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Feliciano J; Department of Oncology at Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland.
  • Wang H; Department of Oncology at Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland.
  • Jaffee EM; Department of Oncology at Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland.
  • Pardoll DM; Department of Oncology at Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland.
  • Topalian SL; Department of Oncology at Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland.
  • Taube JM; Department of Surgery at Johns Hopkins University School of Medicine, Baltimore, Maryland and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland.
Clin Cancer Res ; 26(3): 545-551, 2020 02 01.
Article in En | MEDLINE | ID: mdl-31672770

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pathology, Clinical / Research Design / B7-H1 Antigen / Programmed Cell Death 1 Receptor / Immunotherapy / Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pathology, Clinical / Research Design / B7-H1 Antigen / Programmed Cell Death 1 Receptor / Immunotherapy / Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2020 Document type: Article Country of publication: